Researchers identify new stem cell population important in the growth of colon cancer

June 16, 2015

Researchers at Lawson Health Research Institute have identified a new stem cell population in the colon linked to cancer growth. The findings, which were recently published in the prominent journal Cell Stem Cell, will significantly change the way we study and treat colon cancer.

Colon cancer is the second leading cause of in Canada. It is estimated that in 2015 that 25,100 Canadians will be diagnosed with colon cancer representing 13 percent of all new cancer cases.

Dr. Samuel Asfaha, a clinician-scientist at Lawson and an assistant professor of at the Schulich School of Medicine & Dentistry, Western University, and his colleagues at Columbia University (New York), have identified a previously unknown, long-lived radiation-resistant stem cell population in the colon. Most importantly, they also found that these stem cells can give rise to colonic tumors and sustain their growth. Tissue stem cells are unique cells essential for normal tissue maintenance and regeneration. Their unique characteristic of longevity, however, makes them the most likely cell of origin for cancer. In this study, the researchers sought to identify whether more than one tissue stem cell population exists within the colon which could be a source of colon cancer.

According to Asfaha, the identification of the cellular origin of cancer, specifically , is critical to the understanding of how cancer arises, as well as for the identification of new targets for drug therapy.

"The identification of more than one stem cell pool in the colon has proven challenging," stresse Asfaha. "These findings are exciting as we have identified an important new target for cancer therapy. It is also proof that more than one stem cell can give rise to and sustain tumors, telling us that our cancer therapy needs to target more than one stem cell pool."

Until now, the only stem cell population linked to was radiation sensitive, leading physicians to believe that radiation therapy was effective. "With this new information, we now know this is not always true and we must find new forms of therapy to target the disease," says Asfaha.

Explore further: Potential new colorectal cancer treatment target identified

More information: The study, "Krt19+/Lgr5- cells are radioresistant cancer-initiating stem cells in the colon and intestine' is published in the June 4 issue of Cell Stem Cell.

Related Stories

Potential new colorectal cancer treatment target identified

October 7, 2012
(HealthDay)—The cell surface marker carcinoembryonic antigen-related cell adhesion molecule 6 (CD66c) is a novel marker for colorectal cancer stem cell isolation, which halts tumor growth when silenced, according to research ...

Team discovers novel mechanism controlling lung cancer stem cell growth

April 7, 2015
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many scientists ...

Colon cancer researchers target stem cells, discover viable new therapeutic path

December 1, 2013
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, ...

New study sheds light on cancer stem cell regulation

February 6, 2015
Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have discovered a precise stem cell signaling process that can lead to intestinal tumors if disrupted. The findings add to our understanding of how ...

Recommended for you

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

Suicide molecules kill any cancer cell

October 19, 2017
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules ...

Fundamental research enhances understanding of major cancer gene

October 19, 2017
New research represents a promising step towards better understanding of a key cancer gene. A long-running collaboration between researchers at the Babraham Institute, Cambridge and the AstraZeneca IMED Biotech Unit reveals ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.